IRIS PubliCatt

Chiloiro, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.623
EU - Europa 1.265
AS - Asia 537
AF - Africa 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.612
IT - Italia 282
SE - Svezia 280
DE - Germania 278
SG - Singapore 223
CN - Cina 172
IE - Irlanda 97
ID - Indonesia 74
FR - Francia 62
UA - Ucraina 57
PL - Polonia 54
RU - Federazione Russa 50
GB - Regno Unito 30
FI - Finlandia 22
BE - Belgio 20
IN - India 18
IR - Iran 12
JP - Giappone 12
CA - Canada 11
TR - Turchia 11
HK - Hong Kong 9
CI - Costa d'Avorio 8
NL - Olanda 8
CO - Colombia 4
RO - Romania 4
CZ - Repubblica Ceca 3
PT - Portogallo 3
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
LT - Lituania 2
MD - Moldavia 2
PE - Perù 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
LI - Liechtenstein 1
LK - Sri Lanka 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 3.445
Salva come PNG Salva come JPEG
Città #
Chandler 410
Singapore 171
Ashburn 102
Dublin 84
New York 81
Ann Arbor 78
Jakarta 74
Rome 69
Fairfield 67
San Mateo 57
Warsaw 52
Wilmington 51
Bremen 44
Milan 44
Cattolica 40
Boston 39
Marseille 37
Princeton 34
Seattle 34
Moscow 33
Nanjing 26
Houston 23
Jacksonville 23
Chicago 22
Woodbridge 22
Los Angeles 21
Beijing 20
Brussels 19
Cambridge 19
Munich 17
Boardman 16
Redmond 14
Hangzhou 13
Redwood City 13
Mountain View 12
Dearborn 11
Norwalk 11
Augusta 10
Helsinki 10
Lawrence 10
Hong Kong 9
Nürnberg 9
Abidjan 8
Izmir 8
Kish 8
Kunming 8
Washington 8
West Jordan 8
Zhengzhou 8
Guangzhou 7
Nanchang 7
Piacenza 7
Shenyang 7
Falls Church 6
Fremont 6
London 6
Menlo Park 6
Ottawa 6
Shanghai 6
Andover 5
Lancaster 5
Paris 5
Pune 5
Renton 5
Santa Clara 5
University Park 5
Campobasso 4
Cornaredo 4
Frankfurt am Main 4
Hebei 4
Leawood 4
Mumbai 4
Sakaemachi 4
Bari 3
Brno 3
Coimbatore 3
Dalmine 3
Fuzhou 3
Gunzenhausen 3
Jiaxing 3
Krasnodar 3
Mercato San Severino 3
Nuremberg 3
Petrozavodsk 3
Southend 3
Toronto 3
Ardabil 2
Azzano Decimo 2
Belgrade 2
Berlin 2
Bogen 2
Bogotá 2
Buffalo Junction 2
Cesa 2
Chengdu 2
Chisinau 2
Fort Worth 2
Haikou 2
Jinan 2
Lappeenranta 2
Totale 2.201
Salva come PNG Salva come JPEG
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 233
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 233
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 141
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 136
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 130
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 100
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 96
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 93
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 91
The Changing Clinical Spectrum of Hypophysitis 91
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 86
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 80
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 77
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 67
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 67
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 62
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 60
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 60
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 59
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 58
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 56
Empty sella syndrome: Multiple endocrine disorders. 54
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 54
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 52
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 52
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 52
Understanding the effect of acromegaly on the human skeleton. 51
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 51
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 50
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 49
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 48
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 48
Molecular and Genetic Immune Biomarkers of Primary and Immune-Therapy Induced Hypophysitis: From Laboratories to the Clinical Practice 48
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 48
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature 47
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 46
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 45
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 45
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 43
Acromegaly can be cured by first-line pasireotide treatment? 42
Hypothalamitis and pituitary atrophy 42
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 36
Acromegaly in the elderly patients 36
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 34
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 33
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 31
Interpretable Machine Learning-Based Prediction of Intraoperative Cerebrospinal Fluid Leakage in Endoscopic Transsphenoidal Pituitary Surgery: A Pilot Study 26
Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship 24
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 23
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 21
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy 21
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 19
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 16
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 12
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 11
Reliability of intraoperative visual evoked potentials (iVEPs) in monitoring visual function during endoscopic transsphenoidal surgery 11
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 10
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 10
Consensus on criteria for acromegaly diagnosis and remission 10
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 10
De-escalation treatment with pasireotide for acromegaly: a long-term experience 9
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 9
Letter: A Multicenter, Propensity Score- Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 9
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 8
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 8
From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management? 8
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 7
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 7
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 7
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool 6
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 6
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 5
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 5
The Role of Testosterone in Spermatogenesis: Lessons From Proteome Profiling of Human Spermatozoa in Testosterone Deficiency 4
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 4
Totale 3.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 0 0 0 0 17 25 49 14 17 14 27 12
2020/2021199 13 16 9 18 23 11 23 2 26 28 28 2
2021/2022474 20 11 6 37 76 25 9 85 23 21 54 107
2022/20231.087 132 153 78 190 56 161 61 78 103 19 27 29
2023/2024658 31 121 23 31 35 113 28 10 39 40 85 102
2024/2025366 37 42 122 81 84 0 0 0 0 0 0 0
Totale 3.539